April 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
April 21, 2026
Based on market forecasts, the cough assist devices sector will expand from USD 275.99 million in 2024 to USD 547.99 million by 2034, experiencing a CAGR of 7.24%. In 2024, North America led the global cough assist devices market, while Asia-Pacific is set for the fastest growth. Automatic devices dominated by product type, with mouthpieces le...
April 21, 2026
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for the fastest growth. Contract manufacturing dominated by service, while contract development is set ...
April 21, 2026
According to forecasts, the global active pharmaceutical ingredients CDMO market will grow from USD 127.45 billion in 2024 to USD 260.98 billion by 2034, with an expected CAGR of 7.43%. In 2024, Asia-Pacific led the global API market, while North America is set for strong CDMO growth. Traditional APIs and synthetic synthesis dominated, but antibody...
April 21, 2026
According to forecasts, the global fertility market will grow from USD 36.57 billion in 2024 to USD 87.05 billion by 2034, with an expected CAGR of 9.06%. In 2024, Europe led the global fertility market share by 34%, while Asia-Pacific is set for the fastest growth ahead. Assisted reproductive technology dominated by offerings, while fertility drug...
April 21, 2026
Market insights predict the global cognitive behavioral therapy industry will increase from USD 7.77 billion in 2024 to USD 34.25 billion by 2034, achieving a CAGR of 15.99%. In 2024, North America led the cognitive behavioral therapy market, with cognitive therapy and depression treatment being the dominant segments. Asia Pacific and the anxiety s...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expected to grow significantly. Reagents led the U.S. oncology molecular diagnostics market and will see ...
April 21, 2026
According to market projections, the online therapy services sector is expected to grow from USD 3.84 billion in 2024 to USD 14.10 billion by 2034, reflecting a CAGR of 14.3%. In 2024, North America led the online therapy services market, while Asia-Pacific is set for the fastest growth. Cognitive behavioral therapy dominated by type, but psychodyn...
April 21, 2026
Market insights predicts the genetic material market is set for strong growth from 2025 to 2034, driven by gene therapies, personalized medicine, and biopharma research. North America led in 2024, while Asia Pacific will grow fastest. DNA dominated, but RNA is rising. Genomics led in 2024, with drug discovery and pharma seeing major expansion....
April 21, 2026
According to market projections, the U.S. dental insurance sector is expected to grow from USD 90.02 billion in 2024 to USD 209.46 billion by 2034, reflecting a CAGR of 8.84%. In 2024, DPPOs dominated the dental insurance market, while DHMOs are set for strong growth ahead. Preventive care had the largest share, but basic coverage is expected to ri...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com